Epstein Secrets

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

% 1.3% Average 9.6% 110% Median 9.0% 8.0% 32 EFTA00307427 AliphCom Common Stock Valuation (5000s) As of June 20.2011 Income Approach 2) COSTOF GOODS SOLD Cost of goods sold ("COGS, for fiscal years tÁ11 through 2016 were estimated based on Management's Forecast Management expects to olTer m

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

% 1.3% Average 9.6% 110% Median 9.0% 8.0% 32 EFTA00307326 AliphCom Common Stock Valuation (5000s) As of June 20.2011 Income Approach 2) COSTOF GOODS SOLD Cost of goods sold ("COGS, for fiscal years tÁ11 through 2016 were estimated based on Management's Forecast Management expects to olTer m

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

% 1.3% Average 9.6% 110% Median 9.0% 8.0% 32 EFTA00307225 AliphCom Common Stock Valuation (5000s) As of June 20.2011 Income Approach 2) COSTOF GOODS SOLD Cost of goods sold ("COGS, for fiscal years tÁ11 through 2016 were estimated based on Management's Forecast Management expects to olTer m